IBM: I'm Not Buying Ahead Of Earnings (Preview) (NYSE:IBM)

Looking for more investing ideas like this one? Get them exclusively at Beyond the Wall Investing. Learn More " No Need To Buy IBM Ahead Of Earnings It's been a wild ride this year for International Business Machines Corporation (IBM) shareholders, I guess, with the stock price swinging 20-30-50% up and down throughout Daniel Sereda is chief investment analyst at a family office whose investments span continents and diverse asset classes. This requires him to navigate through a plethora of information on a daily basis. His expertise is in filtering this wealth of data to extract the most critical ideas. He runs the investing group Beyond the Wall Investing in which he provides access to the same information that institutional market participants prioritize in their analysis. Learn more. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. IBM is rated 'Hold' due to a forward P/E of ~17x and projected EPS growth of 6.8%, with downside risk if profitability expands only 6-7% over three years. Risks include weak consensus-beating track record and overvaluation; potential catalysts are improved Consulting segment guidance, deal closure rates, and progress in quantum and AI partnerships. Focus on IBM's ability to maintain its $1 billion FCF target without further productivity cuts and the rate of closing previously slipped deals from Q2.

IBM: I'm Not Buying Ahead Of Earnings (Preview) (NYSE:IBM) | Seeking Alpha

Інші новини компанії